Michael Lees MCom

Michael is an experienced leader in health economics and market access with experience in building teams and successfully working cross-functionally. In the past ten years, he have participated in and led teams responsible for the development and execution of strategy to launch three blockbuster medicines in cardiovascular disease and oncology. In addition to further developing expertise in health economics methodology and market access strategic development, his interests include working with policy experts to understand institutional barriers to access for innovative medicines and the potential solutions to these barriers.